Form 4: Amgen SVP & CCO Nancy A. Grygiel Reports Stock Sale

Nancy A. Grygiel, SVP & CCO of Amgen, reports the sale of 1,589 shares of common stock at a price of $304.4731 per share on February 5, 2025.

Summary

• On February 5, 2025, Nancy A. Grygiel, SVP & CCO of Amgen, sold 1,589 shares of Amgen common stock.
• The sale price was $304.4731 per share.
• Following the transaction, Grygiel directly owns 7,210 shares of Amgen common stock.
• Grygiel also indirectly owns 102.2192 shares through the company's 401(k) plan.
• The reported shares include 114 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This is a routine Form 4 filing, disclosing an insider transaction. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.

Key Dates

Keywords

Form 4, Amgen, Stock Sale, Insider Trading, Grygiel, AMGN, CCO